TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Framework for the North of England, Branded Medicine

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published5
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS Framework for the North of England, Branded Medicine". Published status: complete. Published value: Value not published. 5 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46Bids / Report
1.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published1 Mar 2022, 12:15 GMT
Last source update1 Mar 2022, 12:15 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-02e103
What is being bought
HS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)
What changed
From the official release history
  1. tender value changed
    1 Mar 2022, 12:15 GMT
  2. Status changed to complete
    1 Mar 2022, 12:15 GMT
  3. Official notice release published
    1 Mar 2022, 12:15 GMT
  4. Submission deadline changed to published date
    1 Mar 2022, 12:15 GMT
  5. Published value updated to £863,999,552
    15 Sept 2021, 13:10 BST
  6. Status changed to active
    15 Sept 2021, 13:10 BST
  7. Official notice release published
    15 Sept 2021, 13:10 BST
  8. Submission deadline changed to 20 Oct 2021, 13:00 BST
    15 Sept 2021, 13:10 BST
  9. Buyer information updated
    15 Sept 2021, 13:10 BST
Lots and requirements (5)
Published by the contracting authority
  • Lot 1 · #1
    CM/PHR/20/5600/01 - NHS Framework for the NOFE, Branded Medicines - Tranche B
    cancelled
    Published valueNot published
    CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    CM/PHR/20/5600/02 - NHS Framework for the NOFE, Branded Medicines-Annual Tranche
    cancelled
    Published valueNot published
    CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofE
    cancelled
    Published valueNot published
    CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    CM/PHR/20/5600/04-NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London
    cancelled
    Published valueNot published
    CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 18 months.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaE
    cancelled
    Published valueNot published
    CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    1 Mar 2022, 12:15 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Award active
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Award active
    Not published · Not published
  36. Award active
    Not published · Not published
  37. Award active
    Not published · Not published
  38. Award active
    Not published · Not published
  39. Award active
    Not published · Not published
  40. Award active
    Not published · Not published
  41. Award active
    Not published · Not published
  42. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  43. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  44. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  45. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  46. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  47. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  48. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  49. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  50. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  51. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  52. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  53. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  54. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  55. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  56. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  57. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  58. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  59. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  60. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  61. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  62. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  63. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  64. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  65. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  66. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  67. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  68. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  69. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  70. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  71. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  72. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  73. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  74. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  75. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  76. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  77. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  78. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  79. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  80. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
  81. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £1
Commercial outcome and competition
Awards
Biogen
Not published · Not published · active
Novo Nordisk
Not published · Not published · active
Napp Pharmaceuticals Ltd
Not published · Not published · active
Eli Lilly and Company Ltd
Not published · Not published · active
Ipsen
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
CST Pharma Limited
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Gilead Sciences Limited
Not published · Not published · active
Merck Serono Limited
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
UL Global Pharma
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
Roche Products Ltd
Not published · Not published · active
Bayer Ltd
Not published · Not published · active
Merck Sharpe and Dohme (UK) Limited
Not published · Not published · active
Pfizer Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Janssen-Cilag Ltd
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
Bristol Myers Squibb
Not published · Not published · active
GlaxoSmithKline UK Limited
Not published · Not published · active
Roche Products Ltd
Not published · Not published · active
Merck Sharpe and Dohme (UK) Limited
Not published · Not published · active
Pfizer Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Napp Pharmaceuticals Ltd
Not published · Not published · active
Eli Lilly and Company Ltd
Not published · Not published · active
Amgen Ltd
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
UCB Pharma Ltd
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Gedeon Richter UK Ltd
Not published · Not published · active
Sobi (Swedish Orphan Biovitrum Ltd)
Not published · Not published · active
Contracts
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofE
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaE
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the North of England, Branded Medicines -Tranche B
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
NHS Framework for the NOFE, Branded Medicines-Annual Tranche
£1 · signed 7 Feb 2022, 00:00 GMT · active
Bid statistics
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
bids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
electronicBids: 23 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
smeBids: 4 (lot 1)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
bids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
electronicBids: 20 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
smeBids: 2 (lot 2)
bids: 1 (lot 3)
electronicBids: 1 (lot 3)
bids: 1 (lot 4)
electronicBids: 1 (lot 4)
bids: 1 (lot 5)
electronicBids: 1 (lot 5)
Buyer and organisations in this procedure

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authority GB-FTS-2505
View buyer profile

  • The NHS Commissioning Board (operating under the name of NHS England)
    buyer

    2nd Floor, Rutland House, Runcorn, UK, WA7 2ES
    giorgie.rushton2@nhs.net

  • Accord-UK Ltd
    supplier

    Devon, UKK4

  • Amgen Ltd
    supplier

    Cambridge, UKH12

  • Aventis Pharma ltd t/a Sanofi
    supplier

    Reading, UKJ11

  • Bayer Ltd
    supplier

    Reading, UKJ11

  • Biogen
    supplier

    Maidenhead, UKJ11

  • Bristol Myers Squibb
    supplier

    Uxbridge, UKI74

  • CST Pharma Limited
    supplier

    Walsall, UKG24

  • Celltrion Healthcare United Kingdom Limited
    supplier

    Slough, UKJ1

  • Eli Lilly and Company Ltd
    supplier

    Basingstoke, UKE12

  • Gedeon Richter UK Ltd
    supplier

    Maida Vale - London, UKI3

  • Gilead Sciences Limited
    supplier

    Holborn, UKI31

  • GlaxoSmithKline UK Limited
    supplier

    London, UKI

  • Ipsen
    supplier

    Slough, UKJ1

  • Janssen-Cilag Ltd
    supplier

    High Wycombe, UKJ13

  • Merck Serono Limited
    supplier

    Feltham, UKI6

  • Merck Sharpe and Dohme (UK) Limited
    supplier

    London, UKI31

  • Napp Pharmaceuticals Ltd
    supplier

    Cambridge, UKH12

  • Novo Nordisk
    supplier

    Gatwick, UKJ2

  • Pfizer Ltd
    supplier

    Kent, UKJ4

  • Roche Products Ltd
    supplier

    Garden City, UKH2

  • Sobi (Swedish Orphan Biovitrum Ltd)
    supplier

    Cambridgeshire, UKH12

  • Takeda UK Ltd
    supplier

    London, UKI3

  • Teva UK Limited
    supplier

    Castleford, UKE4

  • The High Court
    reviewBody

    Strand, London, WC2A 2LL
    generaloffice@administrativecourtoffice.justice.gov.uk

  • Thornton and Ross Ltd
    supplier

    Huddersfield, UKE4

  • UCB Pharma Ltd
    supplier

    Slough, UKJ1

  • UL Global Pharma
    supplier

    Hertfordshire, UKH23

  • Zentiva Pharma UK Ltd
    supplier

    London, UKI
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published